United Kingdom

People: argenx SE (ARGX.BR)

ARGX.BR on Brussels Stock Exchange

23 Aug 2019
Change (% chg)

€0.80 (+0.66%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Lanthaler, Werner 

Dr. Werner Lanthaler serves as Non-Executive Independent Vice Chairman of the Board at argenx SE since July 2014. Dr. Lanthaler is the chief executive officer of Evotec AG, a global drug discovery research organization, a position he has held since March 2009. Dr. Lanthaler previously served on the supervisory boards of Bioxell SpA and Pantec Biosolutions AG. Dr. Lanthaler holds a degree in psychology, a Ph. D. in business administration from Vienna University of Economics and Business and a Master’s degree in public administration from Harvard University. He is the chairman of Audit committee, and member of Remuneration and Nomination committee.

Basic Compensation

Total Annual Compensation, EUR 55,000
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 55,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --